| Names | |
|---|---|
| Preferred IUPAC name | 4′,5,7-Trihydroxyflavone |
| Other names | 4′,5,7-Trihydroxyflavone Apigenol NSC 407563 |
| Pronunciation | /əˈpɪdʒ.ə.nɪn/ |
| Identifiers | |
| CAS Number | 520-36-5 |
| Beilstein Reference | 2050082 |
| ChEBI | CHEBI:18388 |
| ChEMBL | CHEMBL95 |
| ChemSpider | 5750 |
| DrugBank | DB06710 |
| ECHA InfoCard | ECHA InfoCard: 100.007.467 |
| EC Number | 3.1.1.73 |
| Gmelin Reference | 73194 |
| KEGG | C10068 |
| MeSH | D03.633.100.221.173.100 |
| PubChem CID | 5280443 |
| RTECS number | **JR8225000** |
| UNII | Z3G5BWZ78S |
| UN number | Not assigned |
| Properties | |
| Chemical formula | C15H10O5 |
| Molar mass | 270.24 g/mol |
| Appearance | Yellow crystalline powder |
| Odor | Odorless |
| Density | Density: 1.4 g/cm³ |
| Solubility in water | Insoluble in water |
| log P | 2.57 |
| Vapor pressure | 6.98E-11 mmHg @ 25°C |
| Acidity (pKa) | 6.74 |
| Basicity (pKb) | 10.99 |
| Refractive index (nD) | 1.889 |
| Dipole moment | 2.65 Debye |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 308.5 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -887.4 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -30729 kJ/mol |
| Hazards | |
| Main hazards | May cause respiratory tract irritation. May cause skin irritation. May cause eye irritation. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07, GHS09 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | P264, P270, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | 1-1-0-~ |
| Flash point | > 208.7 °C |
| Lethal dose or concentration | LD50 (oral, rat): > 4000 mg/kg |
| LD50 (median dose) | > 2,000 mg/kg (rat, oral) |
| NIOSH | Not Listed |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.5–1.25 mg/kg |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds | Luteolin Chrysin Genistein Quercetin Kaempferol Naringenin Diosmetin |
| Parameter | Details | Manufacturer Commentary |
|---|---|---|
| Product Name | Apigenin | Commonly referred to in production paperwork and lab logs as Apigenin. This name is standard across order entries and batch documentation. |
| IUPAC Name | 4′,5,7-Trihydroxyflavone | Chemists in batch records and analytical notes refer to the IUPAC nomenclature to ensure all process steps and documentation align with structurally identical substances. Naming consistency is especially critical for international shipments. |
| Chemical Formula | C15H10O5 | This formula reflects the unhydrated base compound. Any deviation, such as formation of solvates or hydrates during final processing, depends on the solvent system and drying method specified for each grade or customer. |
| Synonyms & Trade Names | Apigetrin (glycoside form), Camomile extract flavone, 5,7,4′-Trihydroxyflavone | Synonyms in processing and shipping documents are chosen based on end-use market. For natural extracts, the trade term often includes botanical references, while synthetic lots use systematic flavone nomenclature. |
| HS Code & Customs Classification | 2932.21 | Customs declarations for bulk Apigenin shipments cite this code for flavones, recognizing its structure under international trade rules. Classification accuracy supports unimpeded shipment; errors here often result from confusion between technical grade and extract forms. |
Apigenin’s isolation and synthesis follow two core routes: extraction from botanical sources, typically Matricaria chamomilla or parsley, or multi-step organic synthesis starting from phloroacetophenone derivatives. Raw material selection starts with controlled botanical supply or validated synthetic precursors, as impurities from either route shape downstream purification challenges.
Batch-to-batch properties, such as residual solvent profile and secondary metabolite content, require grade-specific analytical release. Food, supplement, and research customers each use unique acceptance thresholds. For extracts, residual plant matrix and minor glycosylated forms often influence powder color and solubility, which receive close attention from formulation and QC teams. Synthetic production focuses on minimizing aromatic byproduct formation and incomplete deprotection, especially in the last steps.
Primary control points include solvent quality used in extraction or synthetic phase, reaction pH for flavone ring closure, and temperature management to control hydrolysis during glycoside removal. Filtration and crystallization endpoints depend on target purity, which may require multi-stage recrystallization or preparative chromatography in high-purity pharmaceutical grades. In-process samples check for off-color or trace impurities, which can signal deviation in solvent phase separation or unoptimized wash steps.
Multi-grade production lines set release criteria based on intended end use, with each production campaign undergoing impurity fingerprinting and polymorph checking. Consistency management relies on starting material traceability, in-process verification, and final batch composite review.
Customs documentation requires precise identification due to the nuanced difference between pure Apigenin, botanical powder, and derivative-rich extracts. Incorrect HS coding or ambiguous product naming often delays shipments or triggers further regulatory scrutiny. Packaging, labeling, and documentation are configured to match the recipient jurisdiction’s classification requirements, especially for nutraceutical and pharmaceutical markets.
Industrial-grade apigenin presents as a pale yellow crystalline powder with a negligible odor. The crystalline form and appearance vary in brightness and hue, as influenced by the purification level and residual solvent profile. Melt onset and range are routinely verified during quality control, but typical values are application-driven. Powder flow and bulk density also shift with particle size reduction steps; these factors influence further formulation and tablet compaction performance.
Apigenin shows resistance to hydrolysis under standard dry storage conditions. In our operation, near-neutral pH storage is preferred to minimize oxidative discoloration, as acidic or strongly basic environments prompt decomposition and yellowing. Reactivity with strong oxidants or direct exposure to sunlight can trigger degradation; this is monitored through in-process photostability checks.
Solubility restricts processability: water solubility remains very low, restricting aqueous processing and driving preference for polar organic solvents—ethanol mixtures are common in extraction and recrystallization. Particle surface conditioning has a notable effect on solution clarity, which matters for high-purity requirements or injectable-grade production.
Most production batches are classified into technical and refined grades. Technical grade serves intermediates and general use; refined grades—defined by stricter residual solvent and trace metal content—address pharmaceutical and nutraceutical applications. The final specification is set jointly with the customer based on the regulatory context.
Impurity profiles depend on the extraction source or synthesis impurities. Key contributors include residual solvent (commonly ethanol or acetone traces), by-product flavonoids, and metal residues from catalyst carryover. Regular screens are run using HPLC-UV and ICP-MS where demanded by downstream application.
Typical batch release relies on HPLC purity and loss on drying. The method used aligns with published pharmacopeia monographs if required; otherwise, house-developed protocols validate batch homogeneity and contamination levels.
Our sourcing model prioritizes botanical feedstock quality, routinely switching between parsley, chamomile, or synthetic precursors, depending on cost, availability, and desired impurity footprint. Each sourcing decision considers both pesticidal residue risk and traceability.
Extraction from plant biomass or semi-synthetic buildup from precursors guides route selection. Plant extraction depends on solvent accessibility and residual solvent preference. Synthetic manufacture follows a series of palladium-catalyzed couplings and deprotection steps; route choice affects total throughput and the impurity burden.
Solvent composition, temperature stages, and pH management are key control points to optimize yield and limit unwanted byproducts. Degradation by sunlight or extended heating overrides yield and must be minimized with opaque containment. Purification leverages repeated crystallization and liquid-liquid partitioning; extent of purification is grade-driven.
Routine quality checks evaluate key points: melting range, appearance, purity, loss on drying, and residual solvent. Batch-to-batch repeatability is a focus to support GMP-regulatory frameworks for high-purity product.
Apigenin’s structure supports glycosylation, methylation, and acylation, which manufacturers use to build solubility-modified or bioactivity-enhanced derivatives. Selective reaction at the hydroxyl positions forms glucosides or methyl ethers, with each modification requiring carefully optimized catalyst and solvent systems.
Reactions occur in aprotic or alcoholic solvents with acid or base catalysis, as dictated by the substitution chemistry. Temperature ranges are controlled to avoid charring or unwanted side reactions. High-purity feeds are necessary since trace metals or oxidative residues rapidly degrade yields.
Manufacturers supply custom derivatives, such as apigenin-7-glucoside, dependent on the requirements for food, pharma, or research intermediates. The choice of downstream route follows customer specifications and intended biological application.
Storage at low ambient temperature with desiccant protection slows hydrolytic and oxidative degradation. Each lot is batch-verified for photo-stability, and opaque or amber containers are standard for high-purity product grades. Humidity control reduces agglomeration and discoloration.
Glass or HDPE containers receive preference, as apigenin interacts minimally with these materials, reducing extractables or interaction-induced loss.
Shelf life varies by grade and permissible impurity drift. Significant color change or off-odor signals peroxide build-up or advanced hydrolysis. Retest periods and expiry depend on both intended application and stability data for the given batch.
Hazard class and signal word assignments depend on regulatory jurisdiction and target market. General practice dictates labelling as a mild irritant, though not all batch grades trigger full GHS requirements.
Dust from fine powders requires local extraction. Handling guidelines specify particulate exposure limitation and standard laboratory gloves. Avoidance of inhalation and ingestion is routine guidance.
Acute toxicity tracks at low risk levels for typical adult exposures, but direct dermal or ocular exposure may cause mild irritation—exposure prevention is warranted throughout bulk handling. Workplace air monitoring in blending and packaging zones ensures dust levels do not exceed respiratory nuisance thresholds defined in regional workplace safety guides.
Production output for Apigenin tracks closely with extraction efficiency, raw material sourcing consistency, and available extraction plant throughput. Batch-based extraction systems are most common at scale, with output often limited more by the annualized supply of high-content botanical feedstock than by reactor or downstream process bottlenecks. Commercial supply is more stable for grades tailored to research and pharmaceutical intermediates than specialty food, cosmetic, or nutra grades, where regulatory standards and botanical origin documentation can restrict qualifying feedstock sources. Surge demand or disruptions in the primary cultivation regions of chamomile or parsley—predominant sources—impact supply timelines more than process limitations.
Standard lead times fall in the 3–8 week range for orders aligning with regular extraction slotting and planned shipment dispatches. MOQ is a direct function of batch scale; for higher-purity grades, process economics dictate minimum batch output as the MOQ. Inquiries for off-cycle special grades or non-standard purification levels extend lead times due to changeover cleaning, specific process validation, or extra scrutiny over impurity profiles.
Pack formats vary by customer SOPs and local regulatory handling requirements. Common options include food-grade fiber drums with double-sealed inner liners or high-integrity HDPE carboys for pharma-grade. Custom packaging is subject to validation on a case-by-case basis, often incurring a minimum order surcharge due to material compliance sign-off and repack procedural controls.
Shipping channels depend on regulatory classification and destination. Air freight dominates urgent, low-volume research and pilot orders. Sea/rail routes service industrial volumes to optimize cost and reduce temperature/stress risks. Most shipments are EXW or FOB, contingent on compliance checks at port of departure. Payment terms reflect final customer assessment, with complexity and regulatory destination influencing deposit levels and LC requirements.
Raw material costs consist primarily of dried plant biomass, extraction solvents, and initial purification reagents. The biomass price is the largest variable component, sensitive to harvest yields, global acreage shifts, and regional labor costs. Process route selection (solvent extraction, chromatographic isolation, or crystallization) influences reagent use and solvent recovery burdens, directly swinging costs per unit of API output.
Weather and disease cycles impact both quantity and apigenin content of botanical sources. Export policy changes in key botanical producer countries can block bulk movement or mandate higher documentation, driving up cost and lead time. Volatility in solvent and energy prices compounds risk for solvent-heavy process variants. New regional compliance standards (such as pesticide/listeria standards) can push certain sources out of eligibility, squeezing total market availability.
Grade and purity requirements sit at the core of cost structure and market price variance. Pharmaceutical grades require deeper impurity removal and validated traceability, attracting higher batch costs and packaging expenses due to process segregation. Nutra and food grades tolerate slightly broader impurity bands and lower batch release analytical burdens, reflected in more competitive margins. Packaging with full regulatory documentation or country-specific compliance certifications (Kosher/Halal, etc.) adds cost at both the unit and administrative level, driving further grade-dependent price difference.
Market demand for Apigenin continues to expand in health supplements, food additives, and advanced pharmaceutical research. Recent years have seen sporadic shortages linked to weather and regulatory surprises in the largest cultivation zones. Europe and China supply a lion’s share of botanical feedstock, while downstream processing clusters in India and China offer the broadest range of grades and batch sizes. The US and Japan maintain market share mainly in high-compliance, niche pharmaceutical grade supply contracts.
| Region | Key Role | Characteristic |
|---|---|---|
| US | Pharma R&D, Supplement Brands | Strict QA and traceability; steady high-purity demand |
| EU | Feedstock Production, Ingredient Exports | Tight agricultural controls and batch documentation norms |
| JP | Pharma, Specialty Cosmetic Formulations | Very high documentation, specific impurity profile requests |
| IN | Bulk Extraction & Processing | Cost efficiency, broad portfolio from moderate to high purity |
| CN | Feedstock and Large-Scale Processing | Volume supplier, rapid adaptation to new market standards |
Current market signals suggest moderate upward pressure on standard purity Apigenin pricing by 2026, especially if global regulatory requirements for trace contaminants tighten and climate-linked supply shocks persist. The fastest inflation is likely in >98% grades for pharmaceutical or regulated nutraceutical use, where process and documentation overhead will rise. Expanded state subsidies or certification harmonization across regions could soften the increase for food and cosmetic grades. Input from ongoing agricultural research may help stabilize raw material supply, but volatility remains a risk in the absence of large-scale fallback botanical sources.
Price forecasts utilize raw material market data, historical trade flows, and major regulatory updates, combined with direct feedback from production planning teams and customer forecasts in key markets.
Industry news over the past year highlights escalating interest in trace pesticide and heavy metal content in plant extract-based APIs. Several downstream producers halted release of entire batches pending new method validation, underscoring the rising stringency in acceptance standards across North America and Asia-Pacific markets. At the same time, investment in process upgrades and botanical quality mapping has increased, driven by mid-term supply security efforts and customer demand for provenance tracking.
Recent regulatory drafts in the EU and US propose lower allowable impurity limits for polyphenolic compounds, including Apigenin, which will force all manufacturers procuring botanical feedstock to double down on origin tracking, pesticide screening, and cross-contamination outer loop controls. These drafts push forward deadlines for implementation of revised impurity confirmation methodology, which may impact release lead times.
Plant-based API suppliers continue tightening internal supply chain controls by prioritizing contract grower networks with clean input histories and running parallel raw material validation before committing to extraction runs. On the process side, multi-stage purification is being enhanced to handle new impurity profiles, with process QC checkpoints set as per the most stringent destination market requirement. Cross-market shipment flexibility is being designed into lot release protocols to allow material to transfer to regions with less volatile or more favorable regulatory windows in the event of new compliance barriers.
Apigenin, a naturally occurring flavonoid, finds use across several industries. Manufacturers supply grades tailored for pharmaceuticals, nutraceuticals, food additives, cosmetics, and technical applications. For pharmaceutical formulations, customers request high-purity apigenin for inclusion in oral and topical drug products. Nutraceutical producers work with food-grade or supplement-grade material, focusing on consistent purity and traceability. Food and beverage processers use food additive grades, which prioritize control over contaminants and residual solvents. Cosmetic formulators select cosmetic-grade apigenin, often with documentation on potential allergens and heavy metals. Technical-grade material suits research, industrial, and chemical synthesis applications, where regulatory requirements are less stringent.
| Application | Typical Grade | Key Parameters |
|---|---|---|
| Pharmaceutical | API (Active Pharmaceutical Ingredient) grade | High assay, traceable impurities, controlled residual solvents |
| Nutraceutical / Food Supplement | Food grade or Supplement grade | Pesticides, heavy metals, solvent residues, plant origin documentation |
| Food & Beverage Additive | Food additive grade | Microbial limits, food allergens, limits on processing aids |
| Cosmetics / Personal Care | Cosmetic grade | Allergen profile, topical safety, heavy metal limits |
| Technical / Research | Technical or Analytical grade | Assay, solubility, source impurity profile |
For pharmaceutical applications, controlled substance provenance, batch traceability, and full impurity profiles matter most. The drug master file or equivalent regulatory documentation shapes which release tests control every lot. In nutraceutical and food settings, the biggest focus falls on potential contaminants, non-GMO assurance, and country of botanical origin. In personal care, the facility must demonstrate absence of restricted substances under standards such as REACH or specific regional cosmetic regulations. Technical uses care about availability and batch-to-batch consistency more than ultra-trace impurity levels.
Physical attributes like solubility, particle size, and color can shift based on grade, manufacture route, and source material quality. Manufacturers tune extraction or synthesis parameters to optimize yield, minimize solvent residues, and reduce process-derived byproducts. Specifications lock in these properties at shipment, reflecting the needs of downstream users, the regulatory climate, and ongoing customer feedback.
Determine whether the finished product falls under pharmaceutical, food, cosmetic, or technical use. This influences the range of available grades, documentation, and possible regulatory controls. Each intended application connects directly with risk-control measures and product release decisions.
Understand the compliance framework for your geography—whether that is pharmacopeial, food safety, cosmetic safety, or chemical registration. Some end-uses require certificates of analysis meeting pharmacopeial monographs or food additive standards. Technical support from the manufacturer clarifies which regulatory statements or documentation packages are available for each grade.
Low-level impurities, solvent residues, and biological contaminants directly depend on the grade selection. Pharmaceutical and certain food applications often target low impurity levels and strict solvent cutoff criteria. Technical and research grades may allow for higher impurity tolerances where purity below pharmaceutical standards has no impact on usage. Final product performance or consumer safety considerations determine how closely to control these thresholds.
Higher grades require more intense purification, in-process controls, and analytical investment—often leading to higher costs. Volume requirements guide whether it makes sense to source in multi-kilo bulk packaging or specialty small pack formats. The manufacturer evaluates order scale during commercial discussions to match the right production batch size and packaging configuration.
Before finalizing grade selection, run an application or formulation validation using a representative sample. Quality control teams run confirmatory analysis on all key metrics—assay, impurities, solubility, sensory properties as needed. Batch-to-batch consistency, transport stability, and downstream processing compatibility are checked under real-world handling conditions. Manufacturer technical teams work directly with quality and development teams to resolve open concerns or investigate compatibility issues before commercial supply begins.
Quality expectations for Apigenin draw consistent attention as downstream applications often serve demanding pharmaceutical, nutraceutical, and cosmetic sectors. Our manufacturing is organized under recognized quality management systems aligned to prevailing regulatory requirements for plant extraction and fine chemical production. These certifications demand ongoing internal audits, rigorous traceability for all batches—from raw material harvesting to final lot release—and robust CAPA (Corrective and Preventive Action) systems. Each employee working on the line follows documented SOPs (Standard Operating Procedures), and every deviation from the process route mandates root cause analysis and documented closure.
Application demands drive the level and type of certificates we issue. For pharmaceutical and nutraceutical grades of Apigenin, documentation typically covers GMP production status, allergen absence, and, as requested, non-GMO declaration or Halal/Kosher statements. Only those batches passing full analytical panels, including residual solvents and pesticide residues for extract-derived material, proceed to certification. Testing protocols, acceptance criteria, and the breadth of supporting certificates are always shaped by the end use, customer region, and applicable regulatory requirements.
Batch release for Apigenin involves complete traceability: every shipment ships with a Certificate of Analysis listing results from validated assays and impurity determination. For off-spec or custom grades, detailed analytical method descriptions and process flow diagrams become available for auditing customers. Technical dossiers, including genotoxic impurity assessments and compliance reports for REACH, California Proposition 65, or other local standards, can be supplied depending on the customer’s sector and application. Document formats and language—COA layout, test item nomenclature—follow industry standards unless the client requests otherwise.
Experience shows most industrial customers prioritize uninterrupted supply, especially when Apigenin gets integrated into finished goods subject to strict regulatory oversight. Stability in output hinges on consistent yields from both raw botanical feedstock and purification steps. Our plants reserve core capacity for strategic partners and allocate reserved volumes each quarter based on forecasted requirements, historical uptake, and seasonality in natural source availability. For longer-term projects or unpredictable demand spikes, we support rolling order forecasting or emergency buffer stock by customer contract.
Manufacturing lines operate on multi-batch scheduling to ensure buffer against upstream supply disruptions and shift-to-shift process variability. Raw herb sources undergo supplier qualification and annual re-audits to minimize lot-to-lot active content fluctuations. Key process controls—solvent extraction parameters, evaporation, filtration, and drying routines—get monitored batchwise for yield and impurity profiles. Any deviation triggers batch segregation and quality review before customer release. These steps directly impact lead time, especially for grades with ultra-low impurity tolerances.
Sample requests flow through a standard protocol. The technical support team first reviews end-use application and relevant compliance expectations. Typical sample volumes, grade certification, and background details must be clarified to align deliverables: for regulated sectors, full documentation and batch-specific certificates get attached to sample lots. Turnaround is affected by required grade, purity range, and analytical panel completeness. Industrial customers may send protocols for in-house testing—technical staff coordinate closely to clarify analytical method congruence and receive feedback to fine-tune downstream support.
Business cooperation models are shaped by partner production schedules, order predictability, and sectoral risk management. Standard arrangements include blanket contracts for rolling production and shipment; scheduled call-off orders; or allocation agreements that absorb raw material fluctuations. For emerging projects or uncertain forecasting, we offer pilot-scale supply, tiered pricing based on committed volume, and periodic review of output quality, supply reliability, and mutual adjustments to delivery schedules. Each cooperation plan targets minimized customer downtime and streamlined compliance for onward product release.
Process engineers and chemists continually push for higher yield and lower cost extraction methods for apigenin, particularly from botanical sources such as chamomile and parsley. Most industrial-scale production selects plant materials with proven batch-to-batch consistency in composition to minimize raw material-related impurities. In extractive production, solvent choice and extraction temperature set the major parameters affecting purity and scale-up viability. Teams also focus on improving the selectivity of purification steps, especially during crystallization and chromatographic separation, since by-products and co-extracted flavonoids often complicate the impurity profile.
Recent industrial trends show increasing demand from nutraceutical, pharmaceutical, and cosmetic sectors. Customers in pharma and research chemistry request material grades based on defined impurity thresholds or with documentation of origin, especially for clinical development and functional food applications. In cosmetics, apigenin’s anti-inflammatory characteristics drive requests for microbially controlled batches and custom particle sizes, which in turn add processing and quality control steps in production.
Scaling up apigenin production typically exposes challenges related to raw material variability, solvent recovery, and waste treatment. Teams see significant technical debate in the choice between total synthesis and plant extraction routes. Extractive processes can introduce pesticide residues and plant-specific contaminants; synthetic methods avoid agricultural uncertainty but require strict containment of side products. Long-term cooperation with equipment suppliers and analytical labs has produced progress in traceability and impurity tracking, but purification processes still represent the highest cost and quality control burden. Typical values and impurity profiles are application-dependent and must be specified at the quotation stage.
Market demand for apigenin points to steady growth as formulators in pharmaceuticals, dietary supplements, and cosmeceuticals expand their portfolios. Most projections from sector reports indicate that the nutraceutical segment will contribute the largest absolute growth, with interest especially high in North America and Europe. Expansion of production facilities will depend heavily on improvements in extraction efficiency and environmental performance.
Process innovation focuses on closed-loop solvent systems, new enzymatic isolation technologies, and inline analytics capable of real-time impurity detection. Full lifecycle traceability, including blockchain-style records of lot origin, is gaining traction, especially for pharmaceutical and food-grade product lines. Producers are working with universities and process design firms to develop continuous flow extraction platforms, which could reduce both energy consumption and process time for most application grades.
Sustainable sourcing is increasingly central to customer requirement documents, especially in the European Union and Japan. Certification schemes for pesticide residues and sustainable harvesting practices factor into both raw material contracts and finished product batch approval. Green solvent substitution and reduction of waste solvent emissions remain two of the highest internal targets for cost and environmental compliance. Purification waste and energy use during drying and finishing are topics of ongoing process optimization.
Manufacturing engineers and technical consultants support customer formulation teams at the development stage, clarifying grade selection based on solubility, impurity sensitivity, and stability requirements. Raw material documentation and typical impurity profiles are made available according to the specified grade and application. For pharmaceutical customers, staff provide active support in regulatory filing and analytical verification.
Technical support teams review application-specific queries involving solubility enhancement, heat sensitivity during downstream processing, or compatibility with excipients in nutraceutical compounding. Advice on particle size adjustment, batch homogeneity, and dosing form integration is offered as part of the formal project technical package. Process-specific recommendations must be validated in the customer’s own formulation trials, as performance depends on grade, formulation matrix, and local regulatory restrictions.
Qualified technical follow-up includes support for batch traceability, investigation of anomaly events, and documentation supply for audit needs. Customer feedback feeds into continuous improvement measures for raw material selection, in-process control, and release criteria. For every order, after-sales resources remain available to troubleshoot performance, advise on reformulation, and coordinate additional analytical work if required. Detailed support documentation is provided based on internal standards, contractual agreements, and market-specific regulations.
At our factory, we produce apigenin in dedicated facilities designed for scalable capacity and reliable output. In-house synthesis and direct extraction control every production stage—from raw material handling through precision separation and crystallization. Tight oversight ensures product meets industry benchmarks for purity and assay, supporting high-volume customers and specialty requirements across global markets.
Large-scale food, beverage, and health product firms rely on apigenin as an active ingredient and functional additive. Apigenin contributes to formulations in functional beverages, nutraceutical blending, and selective polymer applications. Demand in the personal care sector has also expanded over the last several years, with formulators integrating apigenin in skin and hair products for specific effects.
Batch production follows validated protocols and GMP standards. We operate a fully equipped analytical laboratory adjacent to main process lines, enabling ongoing monitoring of incoming botanical materials, intermediates, and finished apigenin. HPLC and UV-vis spectrophotometry form the backbone of identity, purity, and contaminant assessment, ensuring deviations do not reach customers. We release material only after verifying assay and residue thresholds meet buyer expectations.
Flexible packaging lines fill fiber drums, foil-lined sacks, or bulk containers depending on downstream handling and transport requirements. Stock rotation and scalable output allow us to support both blanket orders and just-in-time inventory models. Multi-tonne annual output and direct logistics streamline steady deliveries to processors, contract manufacturers, and industrial users.
Our team maintains a strong relationship with technical and procurement teams across client sites. Support covers analytical documentation, traceability, and troubleshooting for formulation or scale-up questions. Industrial buyers receive full access to technical dossiers, COAs, and ongoing QA/QC data. Where formulation or process parameters shift, rapid feedback loops ensure customers can adapt quickly and avoid production delays.
Direct access to a vertically integrated apigenin producer reduces multiple points of risk. Factories managing their own production back quality promises and delivery schedules with physical infrastructure, not secondary claims. Customers benefit from process transparency, predictable supply, and commercial terms aligned with long-term partnership—not spot transactions. Whether integrating apigenin into high-throughput lines or sourcing specialty grades, stakeholders gain an experienced supplier capable of supporting supply chain efficiency and product integrity on an ongoing basis.
In our facility, every batch of Apigenin undergoes a standardized process to ensure chemical purity meets industry expectations for research, supplement, and pharmaceutical applications. Our technical team maintains tight control over raw material sourcing, extraction, and final crystallization steps. Achieving high purity levels isn’t a marketing choice—it’s basic operational integrity. We regularly reach purity benchmarks at or above 98%, based on HPLC analysis. Nothing ships without passing these controls.
The extraction process uses plant raw material, and we opt for food-grade solvents under cGMP protocols. Purity starts with clean inputs and ends with proper post-extraction steps; there’s no shortcut. Filtration, precipitation, and controlled drying—our line supervisors keep these steps in check to avoid cross-contamination or carryover of unwanted components. Routine environmental cleaning, validated by swab tests, prevents contamination.
We validate our Apigenin content using high-performance liquid chromatography (HPLC), a method preferred in both pharma and ingredient manufacturing. Our assay procedure employs a C18 reverse-phase column and diode array detection, which provides a distinct Apigenin peak with minimal interference. Method parameters—such as flow rate, mobile phase composition, and detection wavelength—are fixed after extensive method development by our QC chemists.
We prepare calibration standards from certified reference Apigenin. Each result derives from the comparison of sample peak area to calibration curve standards. Robustness and linearity tests ensure we catch drifts or matrix effects, and our team recalibrates instruments at set intervals. Our lab keeps copies of raw data for every batch, allowing us to provide full traceability if regulatory authorities or auditors request it.
All test results for purity and assay come with a full certificate of analysis for every order shipped. This document summarizes HPLC chromatograms, peak purity analysis, moisture content, and any detectable solvents or impurities. Test procedures align with Pharmacopeial recommendations (like USP or EP, as applicable), ensuring regulators and end-users can readily interpret our claims and methods.
Continuous investment in method validation forms part of our ongoing commitment to quality. Regular internal audits and proficiency testing back up our daily operations. We routinely cross-verify our results with reputable third-party labs to spot-check for analytical drift or unknown biases.
Plant-derived substances like Apigenin present unique challenges—every crop, season, and lot brings natural biological variance. Our solution: stringent raw material selection, consistent supplier qualification, and in-house analytical screening before processing. If any batch falls outside specifications, our team investigates root causes, isolating variables in plant genetics, solvent extraction parameters, or handling procedures.
We know our customers rely on clear, defensible purity and assay data. Apigenin’s biological applications leave no room for guesswork. That’s why our manufacturing lines operate under real-time monitoring, and our analytical records remain transparent and auditable. Stringent reporting and open communication with our customers keep confidence levels high.
Bulk procurement of Apigenin has grown steadily with industry demand. As the manufacturer, we handle every stage of production in-house and maintain a transparent process so customers know exactly what to expect, both in terms of quantity and timing. These two questions—how much and how soon—get straight to the core of business planning for both sides. We have refined our processes, adapting capacity to market shifts and working closely with long-standing clients across the nutraceutical, pharmaceutical, and functional ingredient sectors.
Minimum order quantity is closely tied to our production batch sizing, material sourcing strategy, and the unique requirements of Apigenin extraction. For commercial-scale production, our minimum order quantity starts at 25 kilograms. This threshold reflects batch efficiency and raw material utilization based on extraction yields we achieve with each production round. Processing anything below this volume introduces unnecessary downtime and increases overall cost per kilogram, creating inefficiency that dilutes the advantages of direct-from-factory sourcing.
Buyers seeking to secure a reliable volume for formulation and onward product development should budget for these units as a starting point. Orders above this minimum are welcome; our existing infrastructure supports multi-metric-ton annual outputs and can accommodate short-term surges in demand during market peaks. For recurring requirements, we suggest forecasting at least one quarter ahead, as this strengthens supply chain reliability and locks in optimal scheduling on our lines.
Lead time calculation takes into account raw material procurement, extraction, purification, drying, milling, and final packaging. Once an order is confirmed, our standard delivery window is 3 to 4 weeks for volumes under 500 kilograms. Larger or custom orders may require an additional week for scheduling and processing to ensure all specifications match contractual commitments.
We keep an allocation of raw materials in reserve to support repeat clients and maintain flexibility in case of urgent requirements. Seasonal fluctuations in botanical material availability, or sudden spikes in demand from market trends, occasionally challenge even a robust operation. By working from established production schedules and confirming regular supply with our agricultural partners, we manage to absorb much of this market volatility.
Our technical team performs batch verification at key production stages. Each lot goes through full-spectrum analysis using validated HPLC methods, confirming Apigenin purity and absence of contaminants. Only after passing all controls do we proceed with release and loading. This means we do not promise artificially short lead times only to face rework or quality variance at the last moment. On-time shipping depends on passing our own quality gates, not merely finishing extraction. This is the direct benefit of factory-level oversight and investment in reliable technology—we control outcomes early so customers avoid surprises later.
In summary, buyers engaging in bulk Apigenin procurement can expect minimum quantities starting at 25 kilograms and a typical lead time of 3 to 4 weeks for most standard size orders. Larger or repeat contractual deliveries may be secured through forward-scheduling, drawing on our established sourcing and processing backbone. Customers with nuanced or urgent requirements should coordinate closely with our team for best-fit planning and assurance of timely, direct dispatch.
Shipping Apigenin across borders comes with strict regulatory expectations. Our factory team navigates the complexities of international transport documents every day. No reputable customer wants surprise complications at customs due to missing or incomplete paperwork, nor can anyone afford disruptions from lacking safety data. We see firsthand the pressure our clients feel when it comes to regulatory scrutiny from customs, port authorities, and health agencies across different territories.
We ship our Apigenin product in full alignment with current international transport regulations, including those impacting hazardous and non-hazardous materials. Our logistics and technical staff maintain updated knowledge about the rules affecting air, sea, rail, and road transport for the regions we serve. Before any batch leaves our plant, our compliance officers run a thorough checklist to confirm the packaging, labeling, and accompanying paperwork align with international customer destinations.
Each shipment from our production site includes a full Material Safety Data Sheet (MSDS) and Certificate of Analysis (CoA), both issued from our in-house laboratory. The MSDS outlines physical, chemical, safety, handling, and emergency response information, which assists customers and handlers in taking appropriate measures throughout the supply chain. Our CoA confirms each lot’s test results and analytical profile, including active content and known impurities, as verified using validated in-house methods.
Customs clerks, public health officials, and warehouse partners expect documents to be clear, unambiguous, and signed by the original manufacturer. Handing this off to intermediaries increases opportunities for miscommunication or risky paperwork errors. Our direct involvement means every document and every data point comes from our own lines—not from secondhand sources.
Staying prepared for regulatory updates is essential. Our documentation specialists routinely review new guidelines issued by agencies such as the UN, IATA, and local transport ministries. We keep records up-to-date and adapt templates as regulations evolve. Custom markings, additional certifications, or language translations are added according to the import country’s requirements. Laboratories produce batch-specific CoAs after each production run, including results from our most recent validated quality control tests to support traceability.
Our packaging meets the transport regulations for solid non-hazardous materials, following UN and IMDG shipping codes when those apply. Lot numbers, production dates, and net weights are marked clearly, with secondary labeling if destination authorities require it.
Nothing shuts down a shipment quicker than doubts about a chemical’s documentation—especially where custom controls are tight. By providing every detail directly from our original production files, our documentation empowers our customers’ brokers and logistics teams to process Apigenin shipments without roadblocks. Should authorities have technical questions, our regulatory team responds promptly, using original test results and certified translations if required.
Direct manufacturing responsibility comes with the duty to keep processes clean, current, and transparent. We eliminate gaps between what leaves our plant and what end-users or regulators expect at the destination port. This discipline reduces risk for our clients and for all handlers along the transport chain. As export markets call for stricter compliance, we invest in systems that keep our documentation reliable and our shipments moving without avoidable holdups.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
